| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |